NCT03607890 2026-03-16Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 InhibitorSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2 Active not recruiting38 enrolled